查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1885894

术后恢復蛋白水解物市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Post-Surgical Recovery Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 192 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球术后恢復蛋白水解物市场价值为 23 亿美元，预计到 2034 年将以 7.8% 的复合年增长率增长至 50 亿美元。

术后恢復蛋白水解物市场 - IMG1

市场成长受多种因素驱动，包括人口老化、手术量增加以及实证临床营养实践的持续发展。蛋白质水解物配方技术的进步提高了消化率、疗效和患者依从性，同时随着新兴市场外科营养基础设施的完善，也扩大了其可及性。由于围手术期集中使用以及临床方案和医院处方集的强大影响力，医院和医疗机构管道仍然占据市场主导地位。零售和家庭医疗保健管道贡献了剩余的市场收入，为出院后康復阶段的患者提供服务。优化围手术期营养的趋势，以及蛋白质水解物在外科护理路径中的更广泛应用，将使该市场在未来十年持续成长。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 23亿美元
预测值 50亿美元
复合年增长率 7.8%

2024年，乳清蛋白水解物市占率达到43.8%，预计到2034年将以7.7%的复合年增长率成长。乳清蛋白水解物以其卓越的氨基酸组成（尤其是亮氨酸）而着称，是刺激肌肉蛋白质合成和促进快速恢復的理想选择。其快速吸收的特性确保在30-60分钟内达到血浆氨基酸峰值水平，因此非常适合消化功能受损的术后患者。

2024年，医院市场占比51.8%，预计到2034年将以7.7%的复合年增长率成长。医院仍然是术前和术后蛋白质水解物的主要消费场所。其使用受临床方案、处方集决策和品质指标的指导，这些指标强调减少併发症和缩短患者住院时间。

2024年，北美术后恢復蛋白水解物市场占据33.2%的市场份额，预计到2034年将以7.7%的复合年增长率成长。该地区的市场主导地位得益于人口老化导致的大量手术、超过60%的主要医院广泛采用ERAS方案等临床营养指南、医疗保险和私人保险对肠内营养的有利报销政策，以及雅培营养和雀巢健康科学等主要企业强大的分销网络。

术后恢復蛋白水解物市场的主要参与者包括雅培营养品、雀巢健康科学、费森尤斯卡比、味之素株式会社、百特国际、贝朗医疗、达能纽瓦克健康科学、费森尤斯卡比、味之素株式会社、百特国际、贝朗医疗、达能纽迪希亚、凯特农场、奥尔德萨实验室、美赞臣营养品、美敦力、明治控股、纽迪希亚先进医疗营养、大冼Vitaflo International。这些公司采取的关键策略包括：开发创新蛋白配方以提高吸收率和生物利用度；加强研发投入以提高疗效和患者依从性；拓展新兴市场，完善外科手术基础设施；以及加强与医院和临床营养部门的合作。各公司致力于建立强大的经销网络，确保产品进入药品目录，并提供量身订製的围手术期营养解决方案。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
    • 供应商格局
    • 利润率
    • 每个阶段的价值增加
    • 影响价值链的因素
    • 中断
  • 产业影响因素
    • 成长驱动因素
    • 产业陷阱与挑战
    • 市场机会
  • 成长潜力分析
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特的分析
  • PESTEL 分析
  • 价格趋势
    • 按地区
    • 依配方类型
  • 未来市场趋势
  • 技术与创新格局
    • 当前技术趋势
    • 新兴技术
  • 专利格局
  • 贸易统计
    • 主要进口国
    • 主要出口国（註：仅提供重点国家的贸易统计）
  • 永续性和环境方面
    • 永续实践
    • 减少废弃物策略
    • 生产中的能源效率
    • 环保倡议
  • 碳足迹考量

第四章：竞争格局

  • 介绍
  • 公司市占率分析
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • MEA
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 合作伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估算与预测：依来源划分，2021-2034年

  • 主要趋势
  • 乳清蛋白水解物
  • 酪蛋白水解物
  • 胶原蛋白水解物
  • 禽肉蛋白质水解物
  • 植物性蛋白质水解物

第六章：市场估算与预测：依剂型划分，2021-2034年

  • 主要趋势
  • 标准胜肽基製剂
  • 免疫营养配方
  • 高蛋白/低碳水化合物配方
  • 富含麸酰胺酸的配方
  • MCT增强配方
  • 伤口癒合专用配方

第七章：市场估计与预测：依手术类型划分，2021-2034年

  • 主要趋势
  • 胃肠外科
    • 大肠直肠手术
    • 减重手术
    • 肝胆外科手术
    • 胰臟手术
    • 上消化道手术
  • 肿瘤外科
    • 头颈癌手术
    • 食道癌和胃癌手术
    • 妇科肿瘤手术
    • 膀胱癌手术
    • 大肠直肠癌手术
  • 骨科手术
    • 关节置换手术（膝关节、髋关节）
    • 脊椎外科手术
    • 创伤重建手术
  • 心臟外科手术
    • 冠状动脉绕道手术（CABG）
    • 瓣膜置换手术
    • 心臟移植手术
  • 创伤与烧伤
    • 钝性或穿透性创伤
    • 多重创伤
    • 部分皮层烧伤
    • 全层烧伤
    • 高体表面积烧伤
  • 普通外科和混合外科
    • 疝气修补术
    • 阑尾切除术
    • 胆囊切除术
    • 剖腹探查术

第八章：市场估算与预测：依最终用途划分，2021-2034年

  • 主要趋势
  • 医院
  • 家庭医疗保健
  • 长期照护机构
  • 门诊手术中心

第九章：市场估计与预测：依地区划分，2021-2034年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第十章：公司简介

  • Abbott Nutrition
  • Ajinomoto Co.
  • B. Braun Melsungen
  • Baxter International
  • Cambrooke Therapeutics
  • Danone Nutricia
  • Fresenius Kabi
  • Kate Farms
  • Laboratorios Ordesa
  • Mead Johnson Nutrition
  • Medline Industries
  • Meiji Holdings
  • Nestle Health Science
  • Nutricia Advanced Medical Nutrition
  • Otsuka Pharmaceutical
  • Real Food Blends
  • Solace Nutrition
  • Targeted Medical Pharma
  • Victus
  • Vitaflo International
  • Others
简介目录
Product Code: 15256

The Global Post-Surgical Recovery Protein Hydrolysates Market was valued at USD 2.3 billion in 2024 and is estimated to grow at a CAGR of 7.8% to reach USD 5 billion by 2034.

Post-Surgical Recovery Protein Hydrolysates Market - IMG1

The market growth is driven by multiple factors, including demographic aging, rising surgical volumes, and evolving evidence-based clinical nutrition practices. Technological advancements in protein hydrolysate formulations are improving digestibility, efficacy, and patient compliance, while expanding accessibility in emerging markets with developing surgical nutrition infrastructure. Hospitals and institutional channels continue to dominate the market due to concentrated usage during the perioperative period and strong influence from clinical protocols and hospital formularies. Retail and home healthcare channels contribute the remaining market revenue, serving patients in post-discharge recovery phases. The trend toward optimized perioperative nutrition, combined with broader adoption of protein hydrolysates in surgical care pathways, positions this market for sustained expansion over the next decade.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$2.3 Billion
Forecast Value$5 Billion
CAGR7.8%

The whey protein hydrolysate segment held a 43.8% share in 2024 and is expected to grow at a CAGR of 7.7% through 2034. Recognized for its superior amino acid profile, particularly leucine, whey hydrolysate is ideal for stimulating muscle protein synthesis and supporting rapid recovery. Its quick absorption ensures peak plasma amino acid levels within 30-60 minutes, making it highly suitable for post-surgical patients with compromised digestion.

The hospital segment accounted for a 51.8% share in 2024 and is projected to grow at a CAGR of 7.7% through 2034. Hospitals remain the primary consumption point for protein hydrolysates during the preoperative and postoperative periods. Usage is guided by clinical protocols, formulary decisions, and quality metrics that emphasize reducing complications and shortening patient stays.

North America Post-Surgical Recovery Protein Hydrolysates Market held 33.2% share in 2024, with a projected CAGR of 7.7% through 2034. The region's dominance is supported by a high volume of surgeries among an aging population, widespread adoption of clinical nutrition guidelines such as ERAS protocols in over 60% of major hospitals, favorable reimbursement policies for enteral nutrition through Medicare and private insurance, and strong distribution networks from major players like Abbott Nutrition and Nestle Health Science.

Major players operating in the Post-Surgical Recovery Protein Hydrolysates Market include Abbott Nutrition, Nestle Health Science, Fresenius Kabi, Ajinomoto Co., Baxter International, B. Braun Melsungen, Danone Nutricia, Kate Farms, Laboratorios Ordesa, Mead Johnson Nutrition, Medline Industries, Meiji Holdings, Nutricia Advanced Medical Nutrition, Otsuka Pharmaceutical, Real Food Blends, Solace Nutrition, Targeted Medical Pharma, Victus, Cambrooke Therapeutics, and Vitaflo International. Key strategies adopted by companies in the Post-Surgical Recovery Protein Hydrolysates Market include developing innovative protein formulations that enhance absorption and bioavailability, investing in R&D to improve efficacy and patient compliance, expanding into emerging markets with growing surgical infrastructure, and strengthening partnerships with hospitals and clinical nutrition departments. Firms focus on building robust distribution networks, securing formulary placements, and offering tailored perioperative nutrition solutions.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Source
    • 2.2.3 Formulation type
    • 2.2.4 Surgery type
    • 2.2.5 End use
  • 2.3 TAM Analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By formulation type
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries ( Note: the trade statistics will be provided for key countries only)
  • 3.12 Sustainability and Environmental Aspects
    • 3.12.1 Sustainable Practices
    • 3.12.2 Waste Reduction Strategies
    • 3.12.3 Energy Efficiency in Production
    • 3.12.4 Eco-friendly Initiatives
  • 3.13 Carbon Footprint Considerations

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Source, 2021 - 2034 (USD Million) (Tons)

  • 5.1 Key trends
  • 5.2 Whey Protein Hydrolysate
  • 5.3 Casein Hydrolysate
  • 5.4 Collagen Hydrolysate
  • 5.5 Poultry Protein Hydrolysate
  • 5.6 Plant-Based Protein Hydrolysates

Chapter 6 Market Estimates and Forecast, By Formulation Type, 2021 - 2034 (USD Million) (Tons)

  • 6.1 Key trends
  • 6.2 Standard Peptide-Based Formulations
  • 6.3 Immunonutrition Formulations
  • 6.4 High Protein/Low Carbohydrate Formulations
  • 6.5 Glutamine-Enriched Formulations
  • 6.6 MCT-Enhanced Formulations
  • 6.7 Wound Healing Specific Formulations

Chapter 7 Market Estimates and Forecast, By Surgery Type, 2021 - 2034 (USD Million) (Tons)

  • 7.1 Key trends
  • 7.2 Gastrointestinal Surgery
    • 7.2.1 Colorectal Surgery
    • 7.2.2 Bariatric Surgery
    • 7.2.3 Hepatobiliary Surgery
    • 7.2.4 Pancreatic Surgery
    • 7.2.5 Upper GI Surgery
  • 7.3 Oncologic Surgery
    • 7.3.1 Head and Neck Cancer Surgery
    • 7.3.2 Esophageal and Gastric Cancer Surgery
    • 7.3.3 Gynecologic Oncology Surgery
    • 7.3.4 Bladder Cancer Surgery
    • 7.3.5 Colorectal Cancer Surgery
  • 7.4 Orthopedic Surgery
    • 7.4.1 Joint Replacement Surgery (Knee, Hip)
    • 7.4.2 Spinal Surgery
    • 7.4.3 Trauma Reconstruction Surgery
  • 7.5 Cardiac Surgery
    • 7.5.1 Coronary Artery Bypass Grafting (CABG)
    • 7.5.2 Valve Replacement Surgery
    • 7.5.3 Heart Transplant Surgery
  • 7.6 Trauma & Burns
    • 7.6.1 Blunt or Penetrating Trauma
    • 7.6.2 Polytrauma
    • 7.6.3 Partial Thickness Burns
    • 7.6.4 Full Thickness Burns
    • 7.6.5 High TBSA Burns
  • 7.7 General & Mixed Surgery
    • 7.7.1 Hernia Repair
    • 7.7.2 Appendectomy
    • 7.7.3 Cholecystectomy
    • 7.7.4 Exploratory Laparotomy

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 (USD Million) (Tons)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Home Healthcare
  • 8.4 Long-Term Care Facilities
  • 8.5 Ambulatory Surgical Centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 (USD Million) (Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Abbott Nutrition
  • 10.2 Ajinomoto Co.
  • 10.3 B. Braun Melsungen
  • 10.4 Baxter International
  • 10.5 Cambrooke Therapeutics
  • 10.6 Danone Nutricia
  • 10.7 Fresenius Kabi
  • 10.8 Kate Farms
  • 10.9 Laboratorios Ordesa
  • 10.10 Mead Johnson Nutrition
  • 10.11 Medline Industries
  • 10.12 Meiji Holdings
  • 10.13 Nestle Health Science
  • 10.14 Nutricia Advanced Medical Nutrition
  • 10.15 Otsuka Pharmaceutical
  • 10.16 Real Food Blends
  • 10.17 Solace Nutrition
  • 10.18 Targeted Medical Pharma
  • 10.19 Victus
  • 10.20 Vitaflo International
  • 10.21 Others